Protosthetics and Shabri have announced a partnership to collaborate on the advancement of the application of digital design and additive manufacturing to the Orthotics and Prosthetics industry. The goal of this alliance is to document and better understand the ways to integrate 3D printing of O&P devices into the mainstream fabrication processes of O&P practices.
Protosthetics, with its Galileo program, is the leading managed 3D printing solution for in-clinic manufacturing of O&P products. Based in Fargo and founded in 2015, Protosthetics has served as a leading digital design and additive manufacturing central fabricator for the O&P industry. Shabri is a research and development organization focused on additive manufacturing in O&P, based in Hastings, Nebraska, and has been advancing research in the O&P space in conjunction with Biomechanics Department at University of Nebraska of Omaha since its founding.
Darren Jacoby, CEO of Protosthetics, says that “The partnership between Protosthetics and Shabri will leverage the scale of clinics and patients being served through the Galileo program with the research and clinical trials expertise of Shabri and its university partners. Through this collaboration, current and future Galileo clinics will be able to participate in validated, clinical trials focused on the development and advancement of 3D printed devices in the clinic, as well as get more value from the Galileo program as newly developed devices become available through the program.”
With the years of experience that Shabri brings with its clinical expertise and research work at the University of Nebraska at Omaha, the partnership is poised to advance the development and production of 3D printed prosthetics and orthotics components, as well as expand the amount of practical research in the O&P in the space.
"Shabri is delighted about this partnership with Protosthetics and excited to work together with Protosthetics’ Galileo program designed exclusively for O&P community,” said Rakesh Srivastava, President & CEO of Shabri and Innovative Prosthetics & Orthotics. “This partnership is a continuation of our efforts towards providing the very newest technologies to our O&P clinics and thoroughly understanding how best to integrate these innovations into a productive workflow." Rakesh Srivastava is also a Board Certified Prosthetist & Orthotist with over 25 years of working in the O&P industry and is one of the pioneer researchers in 3D printed upper extremity prosthetics.
Protosthetics was the first central fab facility in the United States to be based solely on 3D printing and CAD/CAM manufacturing. Using this technology means lower costs, shorter lead times, and repeatable, predictable quality each and every time. The introduction of the Galileo System is now bringing 3D printing revolution directly to O&P practices in a new, cost-effective way. Learn more about getting Galileo in your office by reaching out to email@example.com
Founded in 2018 by Rakesh Srivastava, MS, CPO, FAAOP, Shabri was off to a head-start on its path to revolutionize product design and fabrication. At Shabri, we bring a unique approach to designing not only products but also processes. Our engineering and research acumen and additive manufacturing abilities can eliminate many of the barriers standing between a patient and the appropriate life-improving device. We want to partner with you to serve your patients better. Contact us at: www.shabricorp.com
Protosthetics and Shabri have announced a partnership to collaborate on the advancement of the application of digital design and additive manufacturing to the Orthotics and Prosthetics industry
The result was the Galileo program, an end-to-end offering that places 3D printers in clinics while Protosthetics does all the digital design work as requested by clinicians.
Methodist Orthotics and Prosthetics finds immediate success with the Galileo program for managed in-clinic 3D printing
3D Printing Industry Covers Protosthetics' Innovative Galileo Program
Restorative Health Services sees strong financial and turnaround improvements using the Protosthetics Galileo Program for managed in-clinic 3D printing